IMMUNITYBIO, INC. Other Current Liabilities
IMMUNITYBIO, INC. (IBRX) had Other Current Liabilities of $1.44 million as of 2020-12-31, per its 10-K filed 2021-03-04.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:OtherLiabilitiesCurrent · last filed 2021-03-04
- 2020-12-31: Other Liabilities, Current $1.44M.
- 2020-09-30: Other Liabilities, Current $2.30M.
- 2020-06-30: Other Liabilities, Current $3.40M.
- 2020-03-31: Other Liabilities, Current $3.61M.
| Period end | Other Liabilities, Current | Other Liabilities, Current as first filed |
|---|---|---|
| 2020-12-31 | $1.44M 10-K · filed 2021-03-04 | |
| 2020-09-30 | $2.30M 10-Q · filed 2020-11-09 | |
| 2020-06-30 | $3.40M 10-Q · filed 2020-08-07 | |
| 2020-03-31 | $3.61M 10-Q · filed 2020-05-11 | |
| 2019-12-31 | $775.00K 10-K · filed 2021-03-04 | $3.98M 10-K · filed 2020-03-25 |
| 2019-09-30 | $4.29M 10-Q · filed 2019-11-05 | |
| 2019-06-30 | $3.08M 10-Q · filed 2019-08-06 | |
| 2019-03-31 | $3.12M 10-Q · filed 2019-05-08 | |
| 2018-12-31 | $1.67M 10-K · filed 2020-03-25 | |
| 2018-09-30 | $1.92M 10-Q · filed 2018-11-07 | |
| 2018-06-30 | $1.37M 10-Q · filed 2018-08-06 | |
| 2018-03-31 | $1.30M 10-Q · filed 2018-05-07 | |
| 2017-12-31 | $1.37M 10-K · filed 2019-03-13 | |
| 2017-09-30 | $1.36M 10-Q · filed 2017-11-07 | |
| 2017-06-30 | $1.13M 10-Q · filed 2017-08-07 | |
| 2017-03-31 | $939.00K 10-Q · filed 2017-05-08 | |
| 2016-12-31 | $891.00K 10-K · filed 2018-03-12 | |
| 2016-09-30 | $224.00K 10-Q · filed 2016-11-10 | |
| 2016-06-30 | $291.00K 10-Q · filed 2016-08-15 | |
| 2016-03-31 | $363.00K 10-Q · filed 2016-05-16 | |
| 2015-12-31 | $136.00K 10-K · filed 2017-03-15 | |
| 2014-12-31 | $442.00K 10-K · filed 2016-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kymera Therapeutics, Inc. (KYMR) | United States | $9.631B | -31.69 |
| Vaxcyte, Inc. (PCVX) | United States | $8.466B | -7.91 |
| Krystal Biotech, Inc. (KRYS) | United States | $10.210B | 45.56 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| CG Oncology, Inc. (CGON) | United States | $6.095B | -27.95 |
| Scholar Rock Holding Corp (SRRK) | United States | $5.920B | -16.37 |
| CRISPR Therapeutics AG (CRSP) | $5.390B | -11.68 |